Lv3
292 积分 2024-05-24 加入
Risk-adaptive Therapy Guided by Dynamic ctDNA in Nasopharyngeal Carcinoma
1个月前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
1个月前
已关闭
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
2个月前
已完结
Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance
3个月前
已完结
Figures S1-S9, Tables S1-S5, Appendices 2-4 Data Supplementary1 from Apalutamide and Goserelin for Androgen Receptor–Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
3个月前
已完结
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
3个月前
已完结
Head and neck squamous cell carcinoma
4个月前
已完结
Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: A pooled data analysis of two phase III trials
4个月前
已关闭
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
In regard to Vordermark et al. (Int J Radiat Oncol Biol Phys 2004;58:1242–1250)
4个月前
已完结
皖公网安备34019202002308
